Zobrazeno 1 - 10
of 884
pro vyhledávání: '"H. Farkas"'
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-11 (2023)
Abstract TNFRSF10A (tumor necrosis factor receptor superfamily member 10A) encodes a cell surface receptor protein involved in apoptotic, necroptotic, and inflammatory pathways. Dysregulation of TNFRSF10A has been implicated in sensitization to apopt
Externí odkaz:
https://doaj.org/article/576317469deb471f9d53aec97aa27e92
Publikováno v:
Women's Health Reports, Vol 4, Iss 1, Pp 251-261 (2023)
Background: In November 2019, the IWill gender equity pledge campaign called individuals in a health sciences university to make public pledges for gender equity and fostered meaningful dialog to alter mental models and power dynamics. Over 1400 staf
Externí odkaz:
https://doaj.org/article/d6a8219daa3d450c847b398bb07f5221
Autor:
Treefa Shwani, Charles Zhang, Leah A. Owen, Akbar Shakoor, Albert T. Vitale, John H. Lillvis, Julie L. Barr, Parker Cromwell, Robert Finley, Nadine Husami, Elizabeth Au, Rylee A. Zavala, Elijah C. Graves, Sarah X. Zhang, Michael H. Farkas, David A. Ammar, Karen M. Allison, Amany Tawfik, Richard M. Sherva, Mingyao Li, Dwight Stambolian, Ivana K. Kim, Lindsay A. Farrer, Margaret M. DeAngelis
Publikováno v:
Cells, Vol 12, Iss 23, p 2668 (2023)
Age-related macular degeneration (AMD) is a leading cause of blindness, and elucidating its underlying disease mechanisms is vital to the development of appropriate therapeutics. We identified differentially expressed genes (DEGs) and differentially
Externí odkaz:
https://doaj.org/article/e8beab75624a4f28ace7d19d17448129
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background Long noncoding RNAs (lncRNAs) are emerging as a class of genes whose importance has yet to be fully realized. It is becoming clear that the primary function of lncRNAs is to regulate gene expression, and they do so through a varie
Externí odkaz:
https://doaj.org/article/4258f29514b741c1a63133c48f3e1e67
Autor:
Yifan Zhang, Thomas M. Blomquist, Rebecca Kusko, Daniel Stetson, Zhihong Zhang, Lihui Yin, Robert Sebra, Binsheng Gong, Jennifer S. Lococo, Vinay K. Mittal, Natalia Novoradovskaya, Ji-Youn Yeo, Nicole Dominiak, Jennifer Hipp, Amelia Raymond, Fujun Qiu, Hanane Arib, Melissa L. Smith, Jay E. Brock, Daniel H. Farkas, Daniel J. Craig, Erin L. Crawford, Dan Li, Tom Morrison, Nikola Tom, Wenzhong Xiao, Mary Yang, Christopher E. Mason, Todd A. Richmond, Wendell Jones, Donald J. Johann, Leming Shi, Weida Tong, James C. Willey, Joshua Xu
Publikováno v:
Genome Biology, Vol 23, Iss 1, Pp 1-21 (2022)
Abstract Background Clinical laboratories routinely use formalin-fixed paraffin-embedded (FFPE) tissue or cell block cytology samples in oncology panel sequencing to identify mutations that can predict patient response to targeted therapy. To underst
Externí odkaz:
https://doaj.org/article/e207f3a869da4a6c9e54ed39c85b42dd
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
The advent of the Research Domain Criteria (RDoC) approach to funding translational neuroscience has highlighted a need for research that includes measures across multiple task types. However, the duration of any given experiment is quite limited, pa
Externí odkaz:
https://doaj.org/article/b75244a441514564a61ec1bca6411c7e
Autor:
Aneliya Hanineva, Karen Sophia Park, Joshua J Wang, Margaret M DeAngelis, Michael H Farkas, Sarah X Zhang
Publikováno v:
Neural Regeneration Research, Vol 17, Iss 9, Pp 1875-1880 (2022)
Retinal disorders are a group of ocular diseases whose onset is associated with a number of aberrant molecular and cellular processes or physical damages that affect retinal structure and function resulting in neural and vascular degeneration in the
Externí odkaz:
https://doaj.org/article/53a4fc89cc41460eb5c4c880a76b07ab
Autor:
Tapas Ranjan Behera, Jung Min Song, Jennifer Ko, Donald Eicher, Joshua Arbesman, Brian Gastman, Daniel H. Farkas, Pauline Funchain
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Treatment of metastatic melanoma includes the option of targeted therapy in patients with driver BRAF mutations. BRAF-MEK inhibitor drugs improve survival in the approximately 50% of patients with melanoma that harbor BRAF mutations. As BRAF mutation
Externí odkaz:
https://doaj.org/article/03b76a5eb7ff44c0995f116356212541
Autor:
Julie L. Barr, Michael Feehan, Casey Tak, Leah A. Owen, Robert C. Finley, Parker A. Cromwell, John H. Lillvis, Patrice M. Hicks, Elizabeth Au, Michael H. Farkas, Asher Weiner, Andrew L. Reynolds, Sandra F. Sieminski, Richard M. Sherva, Mark A. Munger, Murray H. Brilliant, Margaret M. DeAngelis
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5636 (2023)
Glaucoma is the leading cause of irreversible blindness, affecting 76 million globally. It is characterized by irreversible damage to the optic nerve. Pharmacotherapy manages intraocular pressure (IOP) and slows disease progression. However, non-adhe
Externí odkaz:
https://doaj.org/article/9482716b292743f5932c831fe6bf6ed1
Publikováno v:
Medical Clinics of North America. 107:317-328